Monitoring anti‐CD19 chimeric antigen receptor T cell population by flow cytometry and its consistency with digital droplet polymerase chain reaction

por Cheng, Jiali, Mao, Xia, Chen, Caixia, Long, Xiaolu, Chen, Liting, Zhou, Jianfeng, Zhu, Li
Publicado 2022

Longitudinal Monitoring of Plasma Circulating Tumour DNA Enables the Prediction of Early Relapse in Patients with Non-Hodgkin Lymphoma: A Case Series

por Ji, Hongyan, Long, Xiaolu, Gu, Jia, Jin, Jin, Mao, Xia, Wang, Zhiqiong, Ma, Heng, Chen, Liting
Publicado 2021

Assessment and predictive ability of the absolute neutrophil count in peripheral blood for in vivo CAR T cells expansion and CRS

por Zhang, Man, Long, Xiaolu, Xiao, Yi, Jin, Jin, Chen, Caixia, Meng, Jiao, Liu, Wanying, Liu, Aichun, Chen, Liting
Publicado 2023

Scoring cytokine storm by the levels of MCP-3 and IL-8 accurately distinguished COVID-19 patients with high mortality

por Chen, Liting, Wang, Gaoxiang, Tan, Jiaqi, Cao, Yang, Long, Xiaolu, Luo, Hui, Tang, Qing, Jiang, Tiebin, Wang, Wei, Zhou, Jianfeng
Publicado 2020

TP53-Mutated Circulating Tumor DNA for Disease Monitoring in Lymphoma Patients after CAR T Cell Therapy

por Chen, Liting, Mu, Wei, Gu, Jia, Xiao, Min, Huang, Liang, Zheng, Miao, Li, Chunrui, Xiao, Yi, Zhou, Jianfeng, Long, Xiaolu
Publicado 2021

A Model Perspective Explanation of the Long-Term Sustainability of a Fully Human BCMA-Targeting CAR (CT103A) T-Cell Immunotherapy

por Mu, Wei, Long, Xiaolu, Cai, Haodong, Chen, Caixia, Hu, Guang, Lou, Yaoyao, Xing, Shugang, Wang, Di, Wang, Jue, Xiao, Min, Wang, Kun, Sun, Zhongyi, Li, Chunrui, Zhou, Jianfeng, Chen, Liting
Publicado 2022

CAR T-Cell Therapy Is Effective but Not Long-Lasting in B-Cell Lymphoma of the Brain

por Li, Tongjuan, Zhao, Lei, Zhang, Yuanyuan, Xiao, Yi, Wang, Di, Huang, Liang, Ma, Liya, Chen, Liting, Liu, Songya, Long, Xiaolu, Meng, Fankai, Zhu, Xiaojian, Wei, Jia, Xu, Bin, Zhou, Jianfeng, Zhou, Xiaoxi
Publicado 2020

Long‐term outcomes of relapsed/refractory double‐hit lymphoma (r/r DHL) treated with CD19/22 CAR T‐cell cocktail therapy

por Wei, Jia, Mao, Zekai, Wang, Na, Huang, Lifang, Cao, Yang, Sun, Weimin, Long, Xiaolu, Tan, Jiaqi, Li, Chunrui, Xiao, Yi, Gu, Chaojiang, Zhang, Shangkun, Zhang, Yicheng, Zhang, Tongcun, Zhou, Jianfeng, Huang, Liang
Publicado 2020

CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome

por Chen, Liting, Xu, Bin, Long, Xiaolu, Gu, Jia, Lou, Yaoyao, Wang, Di, Cao, Yang, Wang, Na, Li, Chunrui, Wang, Gaoxiang, Wang, Ying, Zhu, Li, Wang, Jin, An, Haiyun, Xiao, Min, Xiao, Yi, Zhou, Jianfeng
Publicado 2020

Dynamics of Blood Viral Load Is Strongly Associated with Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) Patients: A Prospective Cohort Study

por Chen, Liting, Wang, Gaoxiang, Long, Xiaolu, Hou, Hongyan, Wei, Jia, Cao, Yang, Tan, Jiaqi, Liu, Weiyong, Huang, Liang, Meng, Fankai, Huang, Lifang, Wang, Na, Zhao, Jianping, Huang, Gang, Sun, Ziyong, Wang, Wei, Zhou, Jianfeng
Publicado 2021

A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myeloma

por Wang, Di, Fu, Haiying, Que, Yimei, Ruan, Haitao, Xu, Menglei, Long, Xiaolu, Yu, Qiuxia, Li, Chunhui, Li, Zhe, Cai, Songbai, Chen, Wei, Sun, Cong, Hu, Guang, Wang, Shuai, He, Donggou, Mei, Jianming, Wang, Wen, Li, Chunrui
Publicado 2023

Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations

por Yang, Li, Shen, Ke'Feng, Zhang, Mei'Lan, Zhang, Wei, Cai, Hao'Dong, Lin, Li'Man, Long, Xiao'Lu, Xing, Shu'Gang, Tang, Yang, Xiong, Jie, Wang, Jia'Chen, Li, Deng'Ju, Zhou, Jian'Feng, Xiao, Min
Publicado 2019

Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients

por Chen, Liting, Long, Xiaolu, Xu, Qian, Tan, Jiaqi, Wang, Gaoxiang, Cao, Yang, Wei, Jia, Luo, Hui, Zhu, Hui, Huang, Liang, Meng, Fankai, Huang, Lifang, Wang, Na, Zhou, Xiaoxi, Zhao, Lei, Chen, Xing, Mao, Zekai, Chen, Caixia, Li, Zhen, Sun, Ziyong, Zhao, Jianping, Wang, Daowen, Huang, Gang, Wang, Wei, Zhou, Jianfeng
Publicado 2020